Concepedia

Isabelle Ricard

IR

Statistics

Publications

17

Citations

624

H-Index

15

Active since

1993

Affiliations

Institut Pasteur de Lille(Current)

Inserm

Université de Lille

Institut Pasteur

Centre Hospitalier Universitaire de Lille

Isabelle Ricard is an author at Institut Pasteur de Lille specializing in medicine, microbiology, and pathogenesis.

ORCID

Top concepts

Publications per year

1993–2020

17

Publications

17

The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects.

Richard Béliveau, Denis Gingras, Erwin A. Kruger et al. · PubMed · 2002 · 65 citations

New Insights into How Yersinia pestis Adapts to Its Mammalian Host during Bubonic Plague

Elizabeth Pradel, Nadine Lemaître, Maud Merchez et al. · PLoS Pathogens · 2014 · 56 citations · Full text

Easily synthesized antimalarial ferrocene triazacyclononane quinoline conjugates

Christophe Biot, Jean Dessolin, Isabelle Ricard et al. · Journal of Organometallic Chemistry · 2004 · 53 citations

, , +1

Phenotypic analysis of Yersinia pseudotuberculosis 32777 response regulator mutants: New insights into two-component system regulon plasticity in bacteria

Claire Flamez, Isabelle Ricard, Sonia Arafah et al. · International Journal of Medical Microbiology · 2007 · 51 citations

, , +9

VCAM-1 is internalized by a clathrin-related pathway in human endothelial cells but its α4β1 integrin counter-receptor remains associated with the plasma membrane in human T lymphocytes

Isabelle Ricard, Marcel D. Payet, Gilles Dupuis · European Journal of Immunology · 1998 · 46 citations · Full text

Rows per page

1–5 of 17